
zzso a potent new zzso agent that selectively increases the effect of zzso zzso on poorly zzso tumor tumor cells, was given to 21 patients at New York zzso Medical zzso In 11 of the 21 patients, hearing loss developed secondary to drug zzso In all cases the hearing loss was zzso of cochlear origin, and at least partially zzso There did not seem to be a relationship between degree of hearing loss and age, sex, dose, zzso site of zzso or prior hearing zzso 

